#BEGIN_DRUGCARD DB02121

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
541-35-5

# ChEBI_ID:
50724

# Chemical_Formula:
C4H9NO

# Chemical_IUPAC_Name:
butanamide

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
-0.21

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
1.63E+005 mg/L (at 15 °C)

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Butyramide

# HET_ID:
BMD

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C4H9NO/c1-2-3-4(5)6/h2-3H2,1H3,(H2,5,6)

# InChI_Key:
InChIKey=DNSISZSEWVHGLH-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2121

# Mechanism_Of_Action:
Not Available

# Melting_Point:
114.8 °C

# Molecular_Weight_Avg:
87.1204

# Molecular_Weight_Mono:
87.068413915

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1QNL

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-0.13

# Predicted_LogS:
0.39

# Predicted_Water_Solubility:
2.16e+02 g/l

# Primary_Accession_No:
DB02121

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
10927

# PubChem_Substance_ID:
46507100

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00722

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CCCC(N)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:49 -0700

# Wikipedia_Link:
http://en.wikipedia.org/wiki/Butyramide

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
X13776

# Drug_Target_1_GenBank_ID_Protein:
45271

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
amiC

# Drug_Target_1_Gene_Sequence:
>1158 bp
ATGGGATCGCACCAGGAGCGGCCGCTGATCGGCCTGCTGTTCTCCGAAACCGGCGTCACC
GCCGATATCGAGCGCTCGCACGCGTATGGCGCATTGCTCGCGGTCGAGCAACTGAACCGC
GAGGGCGGCGTCGGCGGTCGCCCGATCGAAACGCTGTCCCAGGACCCCGGCGGCGACCCG
GACCGCTATCGGCTGTGCGCCGAGGACTTCATTCGCAACCGGGGGGTACGGTTCCTCGTG
GGCTGCTACATGTCGCACACGCGCAAGGCGGTGATGCCGGTGGTCGAGCGCGCCGACGCG
CTGCTCTGCTACCCGACCCCCTACGAGGGCTTCGAGTATTCGCCGAACATCGTCTACGGC
GGTCCGGCGCCGAACCAGAACAGTGCGCCGCTGGCGGCGTACCTGATTCGCCACTACGGC
GAGCGGGTGGTGTTCATCGGCTCGGACTACATCTATCCGCGGGAAAGCAACCATGTGATG
CGCCACCTGTATCGCCAGCACGGCGGCACGGTGCTCGAGGAAATCTACATTCCGCTGTAT
CCCTCCGACGACGACTTGCAGCGCGCCGTCGAGCGCATCTACCAGGCGCGCGCCGACGTG
GTCTTCTCCACCGTGGTGGGCACCGGCACCGCCGAGCTGTATCGCGCCATCGCCCGTCGC
TACGGCGACGGCAGGCGGCCGCCGATCGCCAGCCTGACCACCAGCGAGGCGGAGGTGGCG
AAGATGGAGAGTGACGTGGCAGAGGGGCAGGTGGTGGTCGCGCCTTACTTCTCCAGCATC
GATACGCCCGCCAGCCGGGCCTTCGTCCAGGCCTGCCATGGTTTCTTCCCGGAGAACGCG
ACCATCACCGCCTGGGCCGAGGCGGCCTACTGGCAGACCTTGTTGCTCGGCCGCGCCGCG
CAGGCCGCAGGCAACTGGCGGGTGGAAGACGTGCAGCGGCACCTGTACGACATCGACATC
GACGCGCCACAGGGGCCGGTCCGGGTGGAGCGCCAGAACAACCACAGCCGCCTGTCTTCG
CGCATCGCGGAAATCGATGCGCGCGGCGTGTTCCAGGTCCGCTGGCAGTCGCCCGAACCG
ATTCGCCCCGACCCTTATGTCGTCGTGCATAACCTCGACGACTGGTCCGCCAGCATGGGC
GGGGGACCGCTCCCATGA

# Drug_Target_1_General_Function:
Amino acid transport and metabolism

# Drug_Target_1_General_References:
10508151	O'Hara BP, Norman RA, Wan PT, Roe SM, Barrett TE, Drew RE, Pearl LH: Crystal structure and induction mechanism of AmiC-AmiR: a ligand-regulated transcription antitermination complex. EMBO J. 1999 Oct 1;18(19):5175-86.
10708652	O'Hara BP, Wilson SA, Lee AW, Roe SM, Siligardi G, Drew RE, Pearl LH: Structural adaptation to selective pressure for altered ligand specificity in the Pseudomonas aeruginosa amide receptor, amiC. Protein Eng. 2000 Feb;13(2):129-32.
10984043	Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Smith K, Spencer D, Wong GK, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock RE, Lory S, Olson MV: Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature. 2000 Aug 31;406(6799):959-64.
1762155	Wilson SA, Chayen NE, Hemmings AM, Drew RE, Pearl LH: Crystallization of and preliminary X-ray data for the negative regulator (AmiC) of the amidase operon of Pseudomonas aeruginosa. J Mol Biol. 1991 Dec 20;222(4):869-71.
1907262	Wilson S, Drew R: Cloning and DNA sequence of amiC, a new gene regulating expression of the Pseudomonas aeruginosa aliphatic amidase, and purification of the amiC product. J Bacteriol. 1991 Aug;173(16):4914-21.
7813419	Pearl L, O'Hara B, Drew R, Wilson S: Crystal structure of AmiC: the controller of transcription antitermination in the amidase operon of Pseudomonas aeruginosa. EMBO J. 1994 Dec 15;13(24):5810-7.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2634

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
42808

# Drug_Target_1_Name:
Aliphatic amidase expression-regulating protein

# Drug_Target_1_Number_of_Residues:
385

# Drug_Target_1_PDB_ID:
1QO0

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
Not Available

# Drug_Target_1_Protein_Sequence:
>Aliphatic amidase expression-regulating protein
MGSHQERPLIGLLFSETGVTADIERSQRYGALLAVEQLNREGGVGGRPIETLSQDPGGDP
DRYRLCAEDFIRNRGVRFLVGCYMSHTRKAVMPVVERADALLCYPTPYEGFEYSPNIVYG
GPAPNQNSAPLAAYLIRHYGERVVFIGSDYIYPRESNHVMRHLYRQHGGTVLEEIYIPLY
PSDDDVQRAVERIYQARADVVFSTVVGTGTAELYRAIARRYGDGRRPPIASLTTSEAEVA
KMESDVAEGQVVVAPYFSSIDTAASRAFVQACHGFFPENATITAWAEAAYWQTLLLGRAA
QAAGSWRVEDVQRHLYDICIDAPQGPVRVERQNNHSRLSSRIAEIDARGVFQVRWQSPEP
IRPDPYVVVHNLDDWSASMGGGALP

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Negatively regulates the expression of the aliphatic amidase operon. AmiC functions by inhibiting the action of amiR at the protein level. It exhibits protein kinase activity

# Drug_Target_1_SwissProt_ID:
P27017

# Drug_Target_1_SwissProt_Name:
AMIC_PSEAE

# Drug_Target_1_Synonyms:
Not Available

# Drug_Target_1_Theoretical_pI:
5.82

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB02121
